Literature DB >> 1325310

Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane.

B Ljungberg1, S H Jacobson, L E Lins, G Pejler.   

Abstract

The efficacy and kinetics of a low molecular weight heparin fragment (LMWH-fragment, Fragmin) were studied during one hemodialysis session with a highly permeable polysulfone membrane and compared to a second dialysis session using a conventional cuprophane membrane. All patients received 5000 U of Fragmin given as an injection into the arterial line at start of dialysis. The anticoagulative efficacy was evaluated by measuring plasma fibrinopeptide A concentrations. LMWH-fragment concentrations in plasma and ultrafiltrate were determined by an amidolytic activity assay and by a radioimmunoassay using a monoclonal antibody. During hemodialysis with cuprophane and polysulfone membranes the fibrinopeptide A concentrations were low indicating adequate anticoagulation. LMWH concentrations in plasma did not differ in the two membranes at any time. The LMWH-fragment in the ultrafiltrate could neither be detected with the amidolytic assay nor with the radioimmunoassay. We conclude that a single injection of Fragmin effectively prevents clotting during hemodialysis with a highly polysulfone membrane. No significant amounts of the anticoagulant are lost over the dialysis membrane.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325310

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  2 in total

1.  Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration.

Authors:  Manuel Voigt; Michael Gebert; Ulrike Haug; Michael Hulko; Markus Storr; Adriana Boschetti-de-Fierro; Werner Beck; Bernd Krause
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

2.  Effect of nadroparin on anti-Xa activity during nocturnal hemodialysis.

Authors:  Edward Buitenwerf; Arne J Risselada; Eric N van Roon; Nic J G M Veeger; Marc H Hemmelder
Journal:  BBA Clin       Date:  2015-03-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.